Does Discordance Between Baseline Patient ’ s and Evaluator ’ s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis? Data from the EuroSpA Research Collaboration Network

Brigitte Michelsen, Lykke Midtbøll Ørnbjerg, A. G. Loft, T. Kvien, A. Ciurea, H. Mann, K. K. Eklund, A. Yazici, M. J. Santos, J. Askling, Z. Rotar, B. Gudbjornsson, M. Pombo-Suarez, C. Codreanu, I. van der Horst-Bruinsma, E. Kristianslund, M. J. Nissen, K. Pavelka, N. Trokovic, N. InancE. Vieira-Sousa, D. D. Guiseppe, M. Tomsic, A. J. Geirsson, R. Ionescu, M. van de Sande, F. Iannone, C. Sánchez-Piedra, G. Jones, Lise Hejl Hyldstrup, Merete Lund Hetland, Mikkel Østergaard

OriginalsprogEngelsk
Artikelnummer0837
TidsskriftArthritis & Rheumatology
Vol/bind71
Udgave nummerS10
Antal sider3
ISSN1537-2960
StatusUdgivet - 2019

Citationsformater